Cardicomm Solutions, Inc. Press Releases

TSX VENTURE SYMBOL: EKG

CARDIOCOMM SOLUTIONS’ HEARTCHECK AND SMART MONITORING ECG TECHNOLOGIES USED IN COLORADO STATE UNIVERSITY COORDINATED CANINE ATRIAL FIBRILLATION CLINICAL TRIAL

HeartCheck™ ECG Monitors enable pet owners to upload ECGs through GEMS™ Home to veterinarians TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today confirmed a research collaboration with the Colorado State University, College of Veterinary Medicine and Biomedical...

CARDIOCOMM SOLUTIONS NAMES HEARTCHECK™ AND GEMS™ DISTRIBUTOR FOR NEWFOUNDLAND AND LABRADOR

Sales efforts will address access to ECG screening through pharmacies and primary care physician offices in Eastern Canada TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical and consumer provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has engaged Nu-Quest Distribution Inc. (“Nu-Quest”), located in Mount...

CardioComm Solutions Enters Medical Solutions Partnership with Europtima Medical Solutions for HeartCheck™ and GEMS™ WIN Sales in Europe, Africa and the Middle East Region

CardioComm Solutions to be an integral part of Europtima's strategic initiative to introduce state-of-the-art medical solutions overseas TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today confirmed that is has signed a marketing and sales agreement with UAE-based Europtima Medical...

CardioComm Solutions to Release GEMS™ HOME Rx, a HeartCheck™ ECG Based, Low Cost ECG/Arrhythmia Monitoring Solution for Physicians and Medical Services

GEMS™ Home Rx will be released to address a universal need for cost effective arrhythmia monitoring TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) ") a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today confirmed the scheduled November release of "GEMS™ Home Rx" which will enable low cost ECG and arrhythmia monitoring...

The Globe and Mail and EP&T Articles Spotlight the HeartCheck™ ECG PEN’S Growing Global Market and CardioComm Solutions’ Efforts to Improve Wellness Monitoring

Articles coincide with start of investor awareness, increased marketing efforts and direct to pharmacist advertising TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today confirmed coverage of the Company by the Toronto-based The Globe and Mail newspaper and Canadian technology expert,...

CardioComm Solutions and Stockhouse Engage to Launch an Investor Awareness and Brand Recognition Campaign

Campaign to coincide with new HeartCheck™ ECG PEN advertising Initiatives TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced the signing of a 12 month investor awareness program agreement with Stockhouse Publishing Ltd. ("Stockhouse") of Vancouver, Canada. With this...

CardioComm Solutions Announces HeartCheck™ ECG PEN US Retail Pharmacy Consulting Agreement

Agreement is expected to expand sales of the HeartCheck™ PEN ECG device and SMART Monitoring ECG Services TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has entered into a sales and marketing agreement for growing and managing  the Company’s HeartCheck™ ECG related business in drug chains, mass retailers, club retailers, grocery retailers and...

CardioComm Solutions Announces Equity Financing

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it intends to issue 1,818,182 units at a price of $0.055 per unit for gross proceeds of up to $100,000. There is no minimum offering amount. Each unit will be comprised of one common share of the Company and one common share purchase warrant...

Cardiocomm Solutions Closes Shares For Debt Transaction

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical and consumer provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced that it has closed its previously announced shares for debt transaction under which it has issued 1,073,500 common shares of the Company at a deemed price of $0.05 per share to settle debt in the amount of...

CardioComm Solutions Names New Distributor to Drive GEMS™ WIN Sales in French-Speaking Canada

Quebec based distributor closes multiple hospital GEMS™ WIN license sales TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”),a global medical and consumer provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has engaged Quadromed Distribution Inc. ("Quadromed"), located in Montreal, Quebec as its French–Canadian medical technology...

CardioComm Solutions Names New Australian Distributor to Support GEMS™ WIN and HeartCheck™ ECG PEN Sales

Announcement coincides with first Australian hospital GEMS™ WIN license sale TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical and consumer provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into a distributor agreement with Innovative Medical Solutions ("Innovative Medical") located in Perth, Western Australia...

Cardiocomm Solutions issues stock options

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has granted an aggregate of 1,050,060 incentive stock options to members of its board of directors. 250,060 of the options are exercisable at $0.144 per share for five years from the date of grant and vest immediately, 250,000 of the options are...

CardioComm Solutions GEMS™ WIN Enables Wireless Ambulatory ECG Devices to Send Data Through Consumer Smartphones

Global agreement with IntriCon Corporation to expand GEMS™ WIN sales through access to new and cost-effective, wireless ECG devices. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into an ECG device and software distribution and marketing agreement with...

CardioComm Solutions Optimized for HeartCheck™ and GEMS WIN Sale and Operations with ISO Certification Award

Consolidated Resources will Better Serve HeartCheck™, GEMS™ WIN and New Product Sales. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed it has received new regulatory certification from the Canadian Medical Devices Conformity Assessment System (CMDCAS) specifically for its Toronto facilities. Global Business/Product Development, Regulatory, Quality, Development, Service...

CardioComm Solutions to launch the HeartCheck™ ECG PEN with bluetooth for wireless Android and Apple smartphone connectivity

Planned launch will increase market access for device sales and ECG services globally. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram ("ECG") acquisition and management software, announced today that it will introduce a Bluetooth HeartCheck™ PEN for wireless connectivity to Android and Apple Smartphones by Q1 2016. CardioComm Solutions is the...

CardioComm Solutions’ HeartCheck™ ECG PEN is Now Available for Sale in Select Rexall Pharmacies

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, announces the HeartCheck™ ECG PEN is now available on the shelves of select Rexall Pharmacies in Canada. Participating Rexall Pharmacies will display the HeartCheck™ ECG PEN in their diabetes over-the-counter (OTC) section. In-store...

CardioComm Solutions Completes Share Issuance Under HeartCheck™ PEN US Retail Pharmacy Consulting Agreement

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 214,286 common shares of the Company at a deemed price of $0.07 per share, for a total value of $15,000, to an arm's length service provider in settlement of services provided, as previously described in the Company's...

CardioComm Solutions announces distribution and co-marketing agreement for the sale of Braemar wireless event devices utilizing GEMS™ WIN software

Global agreement will provide new hardware wireless device options for GEMS™ WIN clients. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into a three year renewable, non-exclusive, co-marketing and distribution agreement with Minneapolis based Braemar...

Cardiocomm Solutions Announces Shares For Debt Transaction And Issuance Of Stock Options

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 50,000 common shares of the Company at a deemed price of $0.10 per share, for a total value of $5,000, to an arm’s length service provider in settlement of services provided, as previously described in the...

Cardiocomm Solutions Confirms Australian Regulatory Clearance For Over The Counter (OTC) Sales Of The Heartcheck™ ECG PEN

Cardiac Innovations Australia will promote sales of HeartCheck™ devices to medical and retail markets TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced that it has received clearance from the Australian Department of Health, Therapeutics Goods Administration...

CardioComm Solutions to Initiate Sales of the HeartCheck™ ECG PEN Device in 602 Shoppers Drug Mart Pharmacies Across Canada

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has entered into an agreement with Shoppers Drug Mart Inc. (“Shoppers Drug Mart”) for the over-the-counter (“OTC”) sale of the HeartCheck™ ECG PEN device in pharmacies across Canada. The HeartCheck™ ECG PEN has passed regulatory reviews by both Health Canada and the US Food and Drug...

CardioComm Solutions’ Direct Sales Campaign to Place the HeartCheck™ ECG PEN on Shelves of Independent Pharmacy Retailers in Ontario.

HeartCheck™ PEN to be marketed directly to over 500 Independent Retail Pharmacies in Ontario TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, announces they have entered into an agreement with a direct-to-pharmacy sales force for the introduction of the HeartCheck™ ECG PEN for sale into...

CardioComm Solutions Re-Prices Previously Announced Equity Financing

Funding will be used as bridge financing to complete Q1 2014 objectives TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today announced that it has re-priced its previously announced equity financing. The Company will now be conducting a private placement equity financing under which it intends to issue 15,000,000 units at a price of $0.0675 per unit for gross proceeds of $1,012,500. Each unit will be comprised of one...

Cardiocomm Solutions To Migrate Existing MARS® Event Software Users To GEMS™ WIN

MARS® Event Station users to upgrade to GEMS™ WIN and GEMS™ Lite Arrhythmia software in response to discontinued Windows XP and Server 2003 support Toronto, Canada  – CardioComm Solutions, Inc. ( TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions is pleased to announce  a four year agreement with GE Healthcare’s Diagnostic Cardiology...

CardioComm Solutions Confirms Therapeutics Goods Administration Clearance For The Sale Of GEMS™ WIN In Australia

Cardiac Innovations Australia will promote sales of CardioComm Solutions’ Software into local Hospitals and Physician Based Institutions TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced that is has signed an agency agreement with Cardiac Innovations Australia Pty....

CardioComm Solutions Announces Completion Of iMedical Sale Transaction And The Start Of Software Development For Wearable GSM And Mobile Cardiac Telemetry ECG Monitoring

The series of transactions will provide CardioComm Solutions with a recurrent and service-based royalty revenue stream TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirmed today that Toronto-based iMedical Innovations, Inc. (“IMED”) has finalized due diligence reviews and that the series of agreements involving custom software development and royalty license fees executed on...


ECG Monitoring Made Easy

Receive accurate electrocardiogram (‘ECG’ or ‘EKG’) readings in as few as 30 seconds that can then be sent instantly to a physician for review.